Riskpilot← Back to searchSign inGet full accessLiljestam & Co AB
ABActiveOrg 5592259740Nordgången 18Physiotherapy activities · NACE 8695Est. 20192 employees
Revenue 2025
SEK 623K
-31% vs 2024
EBITDA margin
33.1%
-58% vs 2024
Equity ratio
51.7%
Financial strength
Net profit 2025
SEK 163K
-58% vs 2024
| Revenue | SEK 623K | -31% |
| EBITDA | SEK 206K | -58% |
| Net profit | SEK 163K | -58% |
| Total assets | SEK 411K | -36% |
| Equity | SEK 213K | -55% |
| Employees | 2 | — |
Legal name
Liljestam & Co AB
Org number
5592259740
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
8 november 2019
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget kommer att bedriva verksamhet inom medicinsk fotvård och härmed förenlig verksamhet. Bolaget kommer bedriva artistisk verksamhet främst i form av liveframträdanden men även som studiomusiker och konsult inom musikbranschen och härmed förenlig verksamhet.
Address
Nordgången 18
Email
lisaliljestam@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 401 | 656 | 660 | 905 | 623 |
| Staff expenses | — | −146 | −128 | −171 | −110 |
| EBITDA | 133 | 271 | 268 | 489 | 206 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 133 | 271 | 268 | 489 | 206 |
| Net financials | — | 0 | 0 | −0 | −1 |
| Profit before tax | 133 | 271 | 268 | 489 | 206 |
| Tax | −30 | −56 | −56 | −101 | −43 |
| Net profit | 103 | 215 | 212 | 388 | 163 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 285 | 522 | 736 | 646 | 411 |
| Equity | 211 | 426 | 638 | 475 | 213 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 74 | 96 | 98 | 170 | 199 |
| Total debt | 74 | 96 | 98 | 170 | 199 |
EBITDA margin
33.1%
This company
15.8%
Market median
+109% vs market
20212025
Equity ratio
51.7%
This company
38.2%
Market median
+35% vs market
20212025
Return on equity
76.5%
This company
18.4%
Market median
+316% vs market
20212025
Net profit margin
26.1%
This company
8.1%
Market median
+222% vs market
20212025
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
20212025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Liljestam & Co AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunilla Elisabet Liljestam | Chairman | 0 companies |
| Karl Antonhi Morgan Liljestam | Board of Directors | 0 companies |
| Ingrid Madeleine Liljestam | Deputy Board Member | 0 companies |